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Leukemia-associated RhoGEF (LARG) is a novel
RhoGEF in cytokinesis and required for the
proper completion of abscission
Matthew K. Martza, Elda Grabockaa,*, Neil Beeharryb, Timothy J. Yenb, and Philip B. Wedegaertnera
a

Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107; bFox Chase
Cancer Center, Philadelphia, PA 19111

ABSTRACT Proper completion of mitosis requires the concerted effort of multiple RhoGEFs.
Here we show that leukemia-associated RhoGEF (LARG), a RhoA-specific RGS-RhoGEF, is required for abscission, the final stage of cytokinesis, in which the intercellular membrane is
cleaved between daughter cells. LARG colocalizes with α-tubulin at the spindle poles before
localizing to the central spindle. During cytokinesis, LARG is condensed in the midbody,
where it colocalizes with RhoA. HeLa cells depleted of LARG display apoptosis during cytokinesis with unresolved intercellular bridges, and rescue experiments show that expression of
small interfering RNA–resistant LARG prevents this apoptosis. Moreover, live cell imaging of
LARG-depleted cells reveals greatly delayed fission kinetics in abscission in which a population of cells with persistent bridges undergoes apoptosis; however, the delayed fission kinetics is rescued by Aurora-B inhibition. The formation of a Flemming body and thinning of microtubules in the intercellular bridge of cells depleted of LARG is consistent with a defect in
late cytokinesis, just before the abscission event. In contrast to studies of other RhoGEFs,
particularly Ect2 and GEF-H1, LARG depletion does not result in cytokinetic furrow regression nor does it affect internal mitotic timing. These results show that LARG is a novel and
temporally distinct RhoGEF required for completion of abscission.
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INTRODUCTION
Cytokinesis is the final stage of cellular division in which the cell is
physically separated into two daughter cells. The mechanical act of
partitioning the cytoplasm of the cell through ingression of the contractile ring to draw together membrane must be tightly coordinated with the segregation of genetic material. Failure to properly
separate into daughter cells, or a miscue in timing between the
completion of chromosomal segregation and doing so, can lead to
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tetraploidization of the cell, a phenomenon of genetic instability
that has been shown to be beneficial to tumor formation (Fujiwara,
2005). A critical component of this spatiotemporal control involves
the small GTPase RhoA, whose localization and activation are maintained by Rho guanine nucleotide exchange factors (RhoGEFs) and
GTPase-activating proteins (RhoGAPs). It is through the regulation
in the interplay between RhoGEFs and RhoGAPs that RhoA translocates to the equatorial cortex and initiates assembly and ingression
of the contractile ring (Mishima et al., 2002; Bement et al., 2005;
Yüce et al., 2005; Su et al., 2011a; Loria et al., 2012).
A concert of RhoGEFs act during mitosis to ensure proper assembly and ingression of the cytokinetic furrow. MyoGEF has been
shown to interact with the centrosome/spindle pole-associated protein (CSPP) and is necessary for recruitment of ECT2, RhoA, and
nonmuscle myosin II to the central spindle (Asiedu et al., 2009).
ECT2 is recruited to the central spindle and equatorial cortex and is
necessary for cortical localization and activation of RhoA, a critical
step in the establishment of the cleavage furrow at the equatorial
cortex (Tatsumoto et al., 1999; Yüce et al., 2005; Nishimura and
Yonemura, 2006; Petronczki et al., 2007; Wolfe et al., 2009; Su et al.,
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2011b). GEF-H1 was also shown to be important in directing the
activation of RhoA during cleavage furrow ingression and may provide essential communication between the microtubule network
responsible for segregating genomic material and the actomyosindriven furrow ingression process (Krendel et al., 2002; Birkenfeld
et al., 2007; Chang et al., 2008; Fujishiro et al., 2008). Of interest,
studies have yet to uncover a role for a RhoGEF in the regulation of
abscission, the fission of daughter cells after the completion of furrow ingression. Nonetheless, RhoGEFs have been shown to be localized in the dense midbody structure within the intercellular bridge
formed from cytokinetic furrow ingression, suggesting a possible
role post furrow ingression for RhoGEFs.
Leukemia-associated RhoGEF (LARG), also known as ARHGEF12,
is a RhoA-specific RhoGEF first identified as a fusion product with
MLL in acute myeloid leukemia; it remains one of the few RhoGEFs
to be found mutated in human cancers (Fukuhara et al., 2000). LARG
is among a family of RhoGEFs activated by the Gα12/13 G protein
subunits and is also responsible for RhoA activation in signaling
through a diversity of receptors, such as plexin-B1 (Aurandt et al.,
2002; Perrot et al., 2002; Swiercz et al., 2002), insulin-like growth
factor-1 (Becknell et al., 2003; Suzuki et al., 2007), histamine-H1
(Pfreimer et al., 2012), and sphingosine 1-phosphate receptor
(Medlin et al., 2010). Accordingly, LARG has been shown to be involved in cell polarization, cell morphology, and invasion (Swiercz
et al., 2002; Dubash et al., 2007; Kitzing et al., 2007; Goulimari et al.,
2008; Evelyn et al., 2009; Shi et al., 2009), including a report showing that LARG, along with GEF-H1, is critical in regulation of the
mechanical response to force generated on integrins (Guilluy et al.,
2011).
Given the role of LARG in a multitude of mechanical transduction pathways, we sought to determine whether LARG is a member
of the growing assemblage of RhoGEFs critical for proper mitotic
regulation and dynamics. Here we show that LARG is indeed a
novel mitotic RhoGEF displaying a distinct localization pattern with
prominent midbody localization upon furrow ingression and during
abscission. Depletion of LARG results in a late cytokinetic defect,
and together these data show that LARG has a distinct functional
significance from previously determined mitotic RhoGEFs during
abscission.

RESULTS
Immunofluorescence staining of LARG in HeLa cells revealed a dynamic localization pattern through the cell cycle (Figure 1A). In interphase, LARG is predominantly found distributed evenly throughout
the cytoplasm with a concentration colocalizing with α-tubulin at the
microtubule-organizing center (MTOC), similar to localization patterns previously identified for LARG (Goulimari et al., 2008). On initiation of mitosis and through early anaphase, LARG colocalizes with
α-tubulin at the spindle poles and along microtubule tracks, as well
as at the centrosomes. During late anaphase, before initiation of
contractile ring ingression, LARG localizes to the spindle midzone.
We did not find LARG localized at the cortex of the contractile ring,
where ECT2 is known to concentrate just before initiation of ingression (Yüce et al., 2005). Finally, during telophase and cytokinesis,
LARG is prominently localized within the intercellular bridge at the
midbody, or Flemming body, the dense structure formed from the
collapse of the spindle midzone. Strong midbody localization of
LARG was also observed in noncancerous, immortalized RPE-1 cells
(Supplemental Figure S1A), detected by multiple antibodies in HeLa
cells (Supplemental Figure S1B), and lost on small interfering RNA
(siRNA) depletion of LARG in HeLa cells (Supplemental Figure S1, C
and D). RhoA concentrates at the cell cortex before contractile ring
2786 | M. K. Martz et al.

FIGURE 1: Mitotic distribution of LARG. (A, B) HeLa cells were fixed,
and α-tubulin (red), RhoA (red), LARG (green; SC H70), and DNA
(blue) were visualized by immunofluorescence microscopy, as
described in Materials and Methods. Bar, 11 μm.

ingression before condensing in the midbody during cytokinesis
(Nishimura and Yonemura, 2006; Yonemura et al., 2004). Of interest,
it is not until after full contractile ring ingression that LARG is observed to colocalize with RhoA (Figure 1B). Taken together, these
Molecular Biology of the Cell

FIGURE 2: Depletion of LARG results in apoptosis. (A) HeLa cells were treated with non- NS or LARG siRNA as
described in Materials and Methods. Efficiency of endogenous LARG depletion (>90%) is shown by an immunoblot of
cell lysates comparing the LARG signal in LARG siRNA lysates to decreasing equivalents of NS cell lysates. (B) HeLa cells
were treated with LARG siRNA and fixed 12 h after release from double-thymidine G1/S synchronization to enrich for
cells undergoing mitosis. Cells were stained for α-tubulin (red), cleaved caspase-3 (green), and DNA (blue). Images show
examples of normal (top) and apoptotic (bottom) cytokinesis in LARG siRNA–treated cells. Bar, 10 μm. (C) Quantification
of the percentage of cleaved caspase-3–positive cells (**p < 0.05, n = 1438 NS si cells, 1021 LARG si cells). (D) HeLa
cells were transfected with the indicated siRNA together with expression plasmids for mCherry-LARG (Ch-LARG) or the
siRNA-resistant Ch-LARG-5Res and analyzed by immunoblot for PARP-1 cleavage as described in Materials and
Methods. The arrows indicate the position of endogenous LARG (endo) and exogenous mCherry-tagged LARG (exo).
(E) Quantification of PARP-1 cleavage as fold change over control siRNA–treated cells normalized for HSP90 loading
control (*p = 0.0008, **p < 0.02, n = 3 independent experiments).

localization data suggested that LARG may hold functional significance in the midbody after complete furrow ingression during abscission, a novel role both for LARG and for a RhoGEF.
To assess whether the localization of LARG correlated with some
aspects of mitotic progression, we depleted HeLa cells of LARG using siRNA (LARG si; using siRNA #5 as described in Materials and
Methods) and sought to identify any potential mitotic defects (Figure
2A). Of interest, we noted a population of LARG si cells connected
by intercellular bridges with distinct cell death morphologies (Figure
2B). Cells were often found in tandem with drastic membrane disorganization and pyknosis of the nuclei while attached by a membranous extension that contained microtubule bundles, hallmark indications of active apoptosis (Kerr et al., 1972). To confirm that the
morphological changes we observed in LARG si cells were due to
apoptosis, we stained nonspecific siRNA–treated (NS) and LARG si
cells with an antibody targeted against the cleaved form of caspase-3. This staining revealed that LARG si cells displaying severe
morphological changes were positive for cleaved caspase-3 and indeed undergoing apoptosis (Figure 2, B and C). In addition, increased poly[ADP-ribose] polymerase (PARP) cleavage, another
hallmark of apoptosis (Slee et al., 2001), was observed in immunoblots of cell lysates from LARG si cells (Figure 2, D and E). We further
confirmed these data with additional siRNAs targeting LARG in both
pool and individual forms (data not shown). Of importance, the
Volume 24 September 15, 2013

increased apoptosis in LARG si cells was alleviated by introduction
of an siRNA-resistant, mCherry-tagged LARG (Figure 2, D and E).
Thus, on the basis of these observations of increased apoptosis
and apoptotic cells connected by intercellular bridges after LARG
depletion, we postulated that LARG was required for both cell viability and mitotic progression.
To better understand where in mitosis LARG was functionally required, we monitored division by live cell microscopy of HeLa cells
stably expressing green fluorescent protein (GFP)–H2B (Kanda et al.,
1998; Figure 3 and Supplemental Videos S1 and S2). LARG si cells
proceed through early mitosis without any notable error, such as
chromosomal missegregation, chromatin bridges, spindle defects,
or alteration of early mitotic kinetics, as noted by monitoring hallmark chromatin changes during mitosis. Moreover, fixing a parallel
set of LARG si cells just before or after filming, followed by staining
for γ-H2AX (Yang, 2008), revealed no evidence of DNA damage
(data not shown). That we could not detect any decoration of DNA
with staining for γ-H2AX is further confirmation that depletion of
LARG does not affect chromosome integrity or segregation
dynamics.
Depletion of MyoGEF or ECT2 leads to contractile ring assembly
and ingression phenotypes (Tatsumoto et al., 1999; Yüce et al.,
2005; Nishimura and Yonemura, 2006; Wu et al., 2006; Petronczki
et al., 2007; Asiedu et al., 2009; Wolfe et al., 2009; Su et al., 2011b).
LARG is required for abscission
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remained connected by the membranous
intercellular bridge. The postingression midbody remained dense and seemingly well
formed but underwent no further progression toward abscission. Of interest, we observed that a subpopulation of LARG si cells
stuck in this late cytokinesis further underwent apoptosis (Figure 3, A and C). GFPH2B in this subpopulation formed aggregates that were indicative of apoptosis
(Figure 3C and Supplemental Video S3). Of
LARG si cells going through mitosis, 44% of
them died through apoptosis, a threefold
increase over control NS si cells. Moreover,
when specifically examining cells in late cytokinesis, LARG si cells showed a fivefold
increase in apoptosis compared with control
NS si cells (Figure 3, C and D, and Supplemental Video S4). Of note, LARG si cells
spend approximately twice as long in late
cytokinesis as control cells, as described
later (Figure 4). To account for these altered
kinetics, we normalized mitotic apoptosis by
time spent in preingression and postingression stages (Supplemental Figure S2). Overall, LARG si cells display a twofold increase
in time-normalized, mitotic apoptosis. Precytokinesis also represents a twofold increase in apoptosis, a stage in which there is
no difference in time between LARG and NS
si cells. On the other hand LARG si cells display a 2.5-fold increase in late cytokinetic
apoptosis over NS si cells. Although LARG si
cells show a trend toward increased timenormalized apoptosis in cytokinesis as compared to control cells, we have been unable
FIGURE 3: Depletion of LARG results in apoptosis in late cytokinesis. HeLa cells stably
to clearly show significance here. Thus it reexpressing GFP-H2B were treated with the indicated siRNA and synchronized at G1/S by the
mains to be completely resolved whether
double-thymidine method. Cells were released from G1/S block and imaged by live cell
these two phenotypes—increased apoptomicroscopy with times indicated in minutes. (A) Bright-field images of cells progressing through
sis and delayed abscission—that are obmitosis after treatment with indicated siRNAs. Arrows highlight intercellular bridge in LARG
si–treated cells. (B) Representative Western blot of the depletion of LARG in imaged cells.
served upon LARG depletion are distinct or
(C) GFP-H2B and bright-field images of LARG si–treated cells showing the classic degradation of causally linked.
DNA and membrane blebbing indicative of apoptosis after unresolved cytokinesis. Arrows
Introduction of the pancaspase inhibitor
highlight intercellular bridges. (D) Quantification of fates of NS and LARG si–treated cells that
Z-VAD-FMK prevented abscission-related
enter mitosis. Values expressed as a percentage of total number of cells entering mitosis during
apoptosis, and persistent intercellular
filming (**p < 0.0005, n = 262 NS si cells, 297 LARG si cells across three independent
bridges between daughter cells could often
experiments).
be visualized for the length of filming (Supplemental Figure S3). That LARG si cells
These range from an inability to properly assemble the contractile
show full contractile ring ingression but have a significant popularing at the cell cortex to instability and perturbation of the ingrestion that undergoes apoptosis during abscission is a unique phenosion forces. The net result is the regression of the forming cytokitype among the mitotic RhoGEFs and suggests an essential role for
netic furrow to form a binucleate cell. GEF-H1 depletion results in a
LARG in abscission.
more variable phenotype but also ultimately yields incomplete furTo determine at what stage in the late cytokinetic program LARG
row formation and polyploidy (Birkenfeld, 2007). Somewhat surprissi cells become defective, we monitored HeLa cells stably expressingly, unlike depletion of other mitotic RhoGEFs, LARG si cells can
ing GFP-tubulin by live cell microscopy (Figure 4). Microtubules uninitiate contractile ring assembly and ingression without any noticedergo several distinct structural changes during the collapse of the
able perturbations. This is followed by an unremarkable completion
cytokinetic furrow and resolution of the intercellular bridge through
of furrow ingression to form a stable intercellular bridge and dense
abscission (Fededa and Gerlich, 2012). Dense, overlapping microtumidbody structure just before abscission (Figure 3A and Supplebules form at the spindle midzone during anaphase and become
mental Video S2).
compressed in the cytokinetic furrow during contractile ring ingresA difference arose, however, in late cytokinesis. LARG si cells
sion. During late cytokinesis, just before abscission, microtubules
were unable to complete the final fission step. Thus daughter cells
undergo thinning in the intercellular bridge, overlap in the midbody,
2788 | M. K. Martz et al.
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FIGURE 4: Cells depleted of LARG undergo normal mitotic kinetics but are unable to complete abscission. (A) HeLa
cells stably expressing GFP–α-tubulin were treated with the indicated siRNA, synchronized at G1/S by the doublethymidine method, and imaged by live cell microscopy beginning just before initiation of mitosis (times indicated in
minutes). Arrow highlights presence of α-tubulin in LARG si cells well after control NS si cells have completed abscission.
(B) Quantification of mitotic kinetics as measured by α-tubulin dynamics (*p < 0.0001, n = 97 NS si cells, n = 85 LARG si
cells). Total, initiation of mitosis to intercellular α-tubulin resolution; condensation to ingression, initiation of mitosis to
completion of contractile ring ingression; ingression to resolution, completion of contractile ring ingression to
intercellular α-tubulin resolution. (C) HeLa cells were treated with siRNA, fixed 12 h after release from double thymidine,
and stained for α-tubulin (green) and DNA (blue). Arrows highlight intercellular bridges that have completed contractile
ring ingression. LARG si inset highlights Flemming body with proper midbody matrix (red arrow) and distal thinning of
microtubules in the intercellular bridge (flanking white arrows). Bar, 10 μm. (D) Quantification of cells connected by
persistent α-tubulin–containing intercellular bridges as fold over control NS si cells (**p < 0.0005, n ≥1500 cells for each
siRNA across three independent experiments).

and form sites of secondary ingression before being severed just
before fission.
As with data obtained from tracking chromosomal dynamics
(Figure 3), LARG si cells are able to proceed through early mitosis
with comparable kinetics to control siRNA–transfected cells. We observed a significant difference between LARG si and NS si cells upon
completion of furrow ingression and narrowing of tubulin in the intercellular bridge; LARG si cells display a twofold increase in the
time to detect loss of GFP-tubulin signal from the intercellular
bridge, (5.4 vs. 2.6 h in NS si cells), indicative of a defect in abscission or the molecular events immediately preceding abscission
rather than earlier during contractile ring ingression (Figure 4, A and
B). We noted that a population of LARG si cells never resolved tubulin from the intercellular bridge before completion of filming (9 vs.
2% in NS si cells) and others that went through apparent forced
abscission events due to mechanical shearing of the intercellular
bridge.
The inability of LARG si cells to complete abscission results in an
accumulation of G1-like cells that remain connected by tubulincontaining intercellular bridges (Supplemental Figure S4). This is
evidence that in the absence of abscission, cells are still able to
Volume 24 September 15, 2013

undergo subsequent rounds of mitosis. Similar multicellular intercellular bridge accumulation has been seen in other studies of late cytokinetic proteins and complexes, such as Sept9, exocyst complex,
and rab35 GTPase (Gromley, 2005; Estey et al., 2010; Dambournet
et al., 2011).
To achieve higher resolution of the microtubules comprising the
intercellular bridge and detect potential structural abnormalities, we
analyzed postmitotic fixed cells. Cells were either depleted of LARG
or treated with nonspecific control siRNA, synchronized at G1/S by
the double-thymidine method, released by washout, and allowed to
proceed through mitosis. Cells were then fixed 10–12 h postrelease,
when most cells should have completed abscission. Midbody-stage
cells were scored as those with intercellular bridges comprising a
thin microtubule network with a midbody that excluded α-tubulin
antibody due to its dense matrix. LARG si cells displayed a twofold
to threefold increase in persistent, midbody-stage intercellular
bridges (Figure 4, C and D). We further noted that LARG si cells
formed stable midbody bulges displaying hallmark α-tubulin antibody exclusion, as well as distal thinning of microtubules in the
intercellular bridge (Mullins and Biesele, 1977; Steigemann and
Gerlich, 2009; Figure 4C, inset).
LARG is required for abscission
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These data suggest that LARG si cells form a proper midbody
matrix and can assemble the primary abscission machinery but
are unable to complete downstream fission events (Matuliene and
Kuriyama, 2002; Elia et al., 2011). Moreover, apoptosis in LARG si
cells (4–5 h post mitotic initiation) occurs after the time required for
normal completion of cytokinesis and abscission in control NS si
cells (3–4 h post mitotic initiation, as detected by resolution of GFPtubulin from the intercellular bridge). These observations are consistent with the idea that depletion of LARG causes a defect in late
cytokinesis just before abscission, in which a subpopulation of cells
has an increased propensity for apoptosis (Figures 4B and 3, A and
B). We further analyzed the localization of several well-characterized
midbody-associated proteins, including ECT2, TSG101, Aurora-B,
Plk1, RhoA, and Mklp1, and found them to all be properly localized
in LARG si cells (Supplemental Figure S5). With the observed maturity of LARG si intercellular bridges, it was not surprising to find that
interrogated midbody and abscission machinery components were
in well order. Together the data in Figure 4 are consistent with our
hypothesis that LARG is necessary in the very late stages of cytokinesis for the timely completion of abscission.
To begin to address a mechanism by which depletion of LARG
causes a delay in late cytokinesis, we examined whether inhibition of
Aurora-B could bypass the delay. Aurora-B kinase is important not
only in early mitotic dynamics, but also in cytokinesis (Eggert et al.,
2006). Both Aurora-B and the budding yeast homologue lpl1 control an abscission checkpoint in the presence of chromosomal segregation errors. Incomplete clearance of chromosomal material from
the intercellular bridge results in sustained Aurora-B activity and stabilization of the bridge, preventing abscission (Norden et al., 2006;
Steigemann et al., 2009). Moreover, inhibition of Aurora-B activity is
sufficient to relieve the abscission checkpoint in the presence of
nuclear pore formation perturbations (Mackay et al., 2010). Here
asynchronous siRNA-transfected cells were treated with 2 μM
ZM447439, a small-molecule inhibitor of Aurora-B, or dimethyl sulfoxide (DMSO) vehicle for 2 h before fixation. With vehicle treatment, LARG si cells displayed typical increase in persistent intercellular bridges compared to NS si cells (Figure 5, A–C). On inhibition
of Aurora-B, however, in both LARG and NS cells we observed a
significant decrease in the number of midbody stage cells (Figure
5B). Of importance, LARG si displayed a significant decrease in the
number of midbody stage cells even when normalized for the decrease observed with NS si cells (Figure 5C), suggesting that AuroraB activity mediates delayed abscission kinetics in the absence of
LARG. We noted no distinguishable increase in binucleate cell formation between NS and LARG si cells, indicating that the resolution
of intercellular bridges in LARG si cells when treated with ZM447439
was not due to regression of the cytokinetic furrow. In addition, immunofluorescence with an Aurora-B antibody and phospho-specific
Aurora-B antibody to detect active Aurora-B showed midbody localization in NS si and LARG si cells (Supplemental Figure S5), consistent with a role for Aurora-B in mediating delayed abscission upon
LARG depletion.
Finally, by generating a mutant LARG deficient in RhoA activation, we attempted to examine whether the role of LARG in delayed
abscission and apoptosis requires its canonical activation of RhoA.
To generate such a mutant, we tested several different single–amino
acid substitutions, based on previous biochemical and structural
data (Figure 6C; Kristelly et al., 2003; Aittaleb et al., 2009) and assayed for loss of interaction with RhoA-G17A, a nucleotide-empty
form of RhoA. The ability of glutathione S-transferase (GST)–RhoG17A to pull down LARG from cell lysates is a convenient assay for
detecting LARG that is active in terms of RhoGEF activity (Garcia-Mata
2790 | M. K. Martz et al.

FIGURE 5: Cells depleted of LARG undergo an Aurora-B–dependent
delay in abscission kinetics. (A) Asynchronous HeLa cells were treated
with siRNA for 72 h. Cells were treated with either DMSO vehicle or
2 μM ZM447439 to inhibit Aurora-B for 2 h before fixing and staining
for α-tubulin (green) and DNA (blue). Arrows highlight midbody-stage
intercellular bridges. Bar, 10 μm. (B) Quantification of the percentage
of midbody-stage intercellular bridges for both NS si and LARG si
cells in the presence of vehicle or Aurora-B inhibitor (*p ≤ 0.0012,
DMSO vs. ZM447439; DMSO, NS si = 7478 cells, LARG si = 3388 cells;
ZM447439, NS si = 7229 cells, LARG si = 4249 cells; across four
independent experiments). (C) Percentage of midbody-stage
intercellular bridges for LARG si cells normalized by subtraction
of NS si cell percentages for each DMSO and ZM447439 treatment
(*p = 0.0045).

et al., 2006). The LARG-W769A mutant showed a fivefold decrease
in pull down with GST-Rho-G17A compared to wild-type (WT) transfected LARG, whereas the LARG-E790A mutant surprisingly retained
interaction with GST-Rho-G17A (Figure 6A). The LARG-Y940A mutant, however, was completely unable to be pulled down by GSTRho-G17A (Figure 6A), identifying this mutant as a LARG that is incapable of activating RhoA. In our preliminary studies of LARG-Y940A,
we noted that it was difficult to detect its expression. Of interest,
we further noted a drastic decrease in viability in cells transiently
Molecular Biology of the Cell

Wu et al., 2006; Birkenfeld, 2007; Su et al.,
2011b). Depletion of LARG arrests the abscission process, resulting in cells that have
completed contractile ring ingression but
remain unable to complete abscission with
proper kinetics, a temporally distinct requirement from previously identified mitotic
RhoGEFs (Figure 6D). The presence of Flemming bodies with proper midbody matrix
formation in LARG si cells suggests that cells
are able to complete ingression and begin
the proper localization of endosomal-derived components and abscission machinery
but are unable to proceed forward to sever
microtubules and begin the final fission
event (Elia et al., 2011; Neto and Gould,
2011). Moreover, we noted a subpopulation
of LARG si cells with an increased propensity for apoptosis while arrested in late
cytokinesis.
Work on an Aurora-B–controlled checkpoint in abscission (Mackay et al., 2010;
Steigemann, 2009) suggests that the cellular sampling algorithm used to monitor abscission and drive the final outcome of mitotic division is not merely mechanical in
nature but involves multiplexed signaling
FIGURE 6: Y940 of the DH core of LARG is critical for binding to RhoA, and mutation leads to
cascades. Our result showing that treatment
apoptosis. (A) HeLa cells were transfected with indicated plasmid. At 48 h posttransfection, cell
of LARG si cells with an Aurora-B inhibitor
lysates were harvested and subject to GST-G17A-RhoA pull down. Relative binding to RhoA was
allows cells to bypass the delay in abscission
determined by immunoblot for LARG and pull down and input fractions compared for each
suggests that Aurora-B plays an active role
respective LARG plasmid. I, 5% total input; P, 50% total pull down. Top bands, exogenous
in the observed delayed kinetics. Not only is
mCherry-tagged LARG proteins; bottom bands, endogenous LARG. (B) HeLa cells were
this exciting in that it uncovers a likely mechtransfected with indicated plasmid for 48 h, cell lysates harvested, and relative apoptosis
determined by immunoblot for PARP cleavage. (C) Crystal structure of DH/PH domain of LARG
anistic pathway responsible for delayed abin complex with RhoA from PDB database (1X86; Kristelly et al., 2003) depicting residues (pink)
scission kinetics when LARG is depleted
of the DH domain (gray) targeted here in mutation studies and relative locations to RhoA
from cells, it also reveals a novel insight into
(brown). (D) Multiple RhoGEFs exhibit temporally distinct functions for the proper completion of cytokinetic regulation. The Aurora-B abscismitosis. See the text for discussion.
sion checkpoint pathway has been believed
to be chromatin dependent and target the
overexpressing this mutant compared to WT LARG. This led us to
clearance of genetic material from the intercellular bridge, although
hypothesize that LARG-Y940A, which cannot bind to RhoA, causes
additional work suggests that this checkpoint is also activated when
apoptosis in a dominant-negative manner. Indeed, we observed innuclear pores are not reformed properly (Mackay et al., 2010). We
creased PARP cleavage with overexpression of LARG-Y940A (Figure
showed that depletion of LARG does not disrupt normal chromosomal segregation fidelity. Yet, when LARG is absent, cells are un6B). Surprisingly, we also observed increased apoptosis in cells exable to satisfy the Aurora-B–mediated abscission checkpoint. Thus
pressing LARG-E790A and, to a lesser degree, LARG-W769A. These
our results propose a nuclear- and chromatin-independent mechaobservations of increased apoptosis upon expression of RhoGEF
activity–deficient LARG suggest that LARG-Y940A, and possibly the
nism of sustained checkpoint activity. These data suggest a more
other mutants, are functioning in a dominant-negative manner and
omnipotent abscission checkpoint, one that ensures not only proper
thus are consistent with our results here using siRNA depletion of
completion of cytokinesis in monitoring chromosomal clearance,
LARG. Further, these data suggest that RhoA activation is required
but also a multitude of convergent mechanical and biochemical sigfor LARG’s role in maintaining cell viability and, by extension, LARG’s
naling pathways.
role in late cytokinesis. We were unable to directly test this; the fact
LARG is not the first regulator of cytokinesis or abscission whose
that LARG-Y940A promotes apoptosis prevented us from using it in
disruption results in apoptosis; however, LARG and GEF-H1 appear
siRNA rescue experiments and makes it technically challenging to
to be exclusive as RhoGEFs whose cytokinetic impairment can result
identify late-cytokinesis cells expressing this mutant of LARG.
in cell death (Tomas, 2004; Birkenfeld, 2007; Pohl and Jentsch,
2008; Estey et al., 2010). Outcomes in which daughter cells are not
DISCUSSION
properly separated result in a state of cellular aneuploidy, genetic
The studies presented here show a novel and specific role for LARG
instability beneficial for tumor formation and growth, as well as inin cytokinesis. Depletion of previously identified mitotic RhoGEFs
creased susceptibility to transformation after carcinogenic exposure
results in cytokinetic defects ranging from the inability to properly
(Fujiwara, 2005). A common therapeutic approach for targeting
initiate contractile ring ingression to cortical instability and failure to
mitotic cells is to use antispindle agents, such as vinca alkaloids and
fully ingress and form the cytokinetic furrow (Tatsumoto et al., 1999;
taxanes. However, populations of cells can undergo slippage out of
Volume 24 September 15, 2013
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this block, continuing mitotic division and thus proliferating with potentially increased genetic instability (Rieder and Palazzo, 1992;
Di Leonardo et al., 1997; Tao et al., 2005). Therefore proteins that
regulate processes downstream of spindle assembly, such as mitotic
exit, provide alternative anticancer targets (Huang et al., 2009).
LARG and other proteins whose disruption likewise results in apoptosis during failed abscission rather than furrow regression and aneuploidy pose therapeutically enticing targets. One important question that remains to be answered is exactly how and when apoptosis
is being triggered. Further, it is not understood whether the cytokinetic defect and resultant delay may be causing apoptosis and, if so,
the mechanistic derivation of this signal. Finally, although siRNAresistant LARG could rescue the increased apoptosis caused by
LARG depletion, we could not consistently observe overexpressed
LARG at the midbody. Thus it remains unresolved whether midbody
localization of LARG is essential for its antiapoptotic function.
RhoGEFs identified as necessary for mitosis have proven to be
critical for the proper assembly, constriction, and stability of the contractile ring. There appear to be, however, no previously shown
postingression phenotypes during late cytokinesis and subsequent
abscission when these RhoGEFs are siRNA depleted. This posed
the intriguing question as to whether regulation of RhoA activity is a
crucial step in late cytokinesis and, correlatively, if there is a functionally relevant RhoGEF after complete contractile ring ingression necessary for the completion of abscission. Recent work revealed a role
for citron kinase (CIT-K) upstream of RhoA at the midbody stage of
cytokinesis (Gai et al., 2011). Overexpression of CIT-K results in increase in active RhoA in late cytokinesis, leading to abscission delay
that can be rescued by inactivation of RhoA by C3-toxin. Conversely,
depletion of CIT-K results in significant reduction of active RhoA in
late cytokinesis and, of interest, reduction in the total RhoGEF activity at this stage. It was noted, however, that no disruption in localization or activity of the canonical mitotic RhoGEFs ECT2 and GEF-H1
or RhoGAPs p190RhoGAP and RACGAP1 could be observed with
CIT-K depletion. Therefore it is likely that the CIT-K and RhoA pathway in late cytokinesis is connected to a yet-unfound mitotic RhoGEF. Given that depletion of LARG from cells results in an abscission
delay and sustained Aurora-B checkpoint activity, it is a rather fitting
candidate for such a role. It will therefore be exciting to determine
the late cytokinetic interactome of LARG and whether it is indeed
cooperating with CIT-K to control the activity and stable localization
of RhoA just before abscission.
Mutational analysis of LARG DH–domain residues showed that
Y940 is critical for binding to RhoA and, further, that LARG-Y940A
appears to act in a dominant-negative manner, ultimately causing
apoptosis. Cells depleted of LARG have a high propensity for abscission-related apoptosis while attempting to undergo cytokinesis.
Given that overexpression of LARG-Y940A, which is completely unable to bind RhoA, also results in apoptosis, we hypothesize that
these are related phenotypes and that LARG binding to RhoA is
important for cell viability. We anticipate that this regulation of RhoA
activity is critical for proper late cytokinesis and abscission kinetics
and, ultimately, viability in cytokinesis. Further experimentation is
needed, however, to confirm that these are interconnected phenomena. Further studies should elucidate with finer detail the temporal requirement for LARG in abscission and whether there is a
functional requirement for discrete RhoA activation during certain
events in the abscission process after completion of contractile ring
ingression.
In summary, this study shows that depletion of LARG causes a delay in late cytokinesis and thus provides evidence for an unexpected
mitotic role for LARG. Further understanding of the molecular
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requirement for LARG in late cytokinesis should provide crucial
insight into the upstream modalities of abscission regulation.

MATERIALS AND METHODS
Cell culture, plasmids, and transfections
Cell lines were cultured in either DMEM (HeLa) or 50:50 DMEM:F12
(RPE1) with 10% fetal bovine serum at 37°C and 5% CO2. mCherryLARG (Ch-LARG) was constructed as previously described (Grabocka
and Wedegaertner, 2007). Cells were transfected in six-well plates
with HiPerFect (Qiagen, Valencia, CA) for siRNA or Lipofectamine
2000 (Invitrogen, Carlsbad, CA) for siRNA and plasmid cotransfection. For siRNA depletion experiments, cells were transfected with
either NS control siRNA (D-001810-01) or those targeted against
LARG, ARHGEF12 siGenome ON-TARGET plus set (J-008480;
Dharmacon, Lafayette, CO), at 50 nM concentration using the manufacturer’s instructions. LARG siRNA #5 was used for further singlesiRNA studies (J-008480-05, GAUCAAAUCUCGUCAGAAA). Cells
were then harvested 48–72 h later unless otherwise noted. siRNA
resistance (Ch-LARG-5res) was generated by introduction of silent
mutations into the LARG siRNA #5 binding sequence of Ch-LARG
by QuikChange mutagenesis (GATCAAAAGTCGTCAGAAA). DHdomain mutants were constructed by QuikChange PCR mutagenesis of W769 (mCh-LARG-W769A), E790 (mCh-LARG-E790A), or
Y940 (mCh-LARG-Y940A) to alanine in mCherry-LARG (Ch-LARG).

Immunoblotting
Cells were lysed and subjected to standard immunoblotting procedures using overnight incubation of primary antibodies with 1 h of
secondary antibody incubation. Primary antibody dilutions were
anti-LARG, 1:2000 (goat RD AF4737, R&D Systems, Minneapolis,
MN; rabbit A301-959A, Bethyl Laboratories, Montgomery, TX; rabbit H70, Santa Cruz Biotechnology, Santa Cruz Biotechnology, CA);
rabbit anti-PARP1, 1:2000 (Santa Cruz Biotechnology); mouse anti–
α-tubulin, 1:2000 (DM1A; Sigma-Aldrich, St. Louis, MO); and rabbit
anti-HSP90 α/β, 1:25,000 (Santa Cruz Biotechnology). Secondary
antibody coupled to horseradish peroxidase was used at 1:10,000
(Promega, Madison, WI). Densitometry of Western blots was performed using Quantity-One (Bio-Rad, Hercules, CA).

Immunofluorescence
Cells were washed with phosphate-buffered saline and fixed in either 10% trichloroacetic acid at 4°C for 10 min or 3.7% paraformaldehyde at 24°C for 15 min. Cells were then permeabilized by blocking in 1% Triton X-100 in Tris-buffered saline containing 2.5% nonfat
milk or bovine serum albumin. Primary antibodies were incubated
for 1.5 h and secondary antibodies for 0.5 h. Primary antibody dilutions were anti-LARG, 1:1000 (goat RD AF4737, R&D Systems; rabbit A301-959A, Bethyl Laboratories; rabbit H70, Santa Cruz Biotechnology); rabbit anti–cleaved caspase-3, 1:1000 (Cell Signaling
Technology, Beverly, MA); mouse anti-RhoA, 1:500 (sc-179, Santa
Cruz Biotechnology); rabbit anti-MKLP-1 (N-19, Santa Cruz Biotechnology), mouse anti-TSG101 (ab83; Abcam, Cambridge, MA), rabbit anti-ECT2 (sc-25637; Santa Cruz Biotechnology), mouse antiPLK1 (05-844, clone 35-206; Millipore, Temecula, CA), Mklp1
(sc-867, Santa Cruz Biotechnology), rabbit anti–Aurora-B pT232
(Rockland, Gilbertsville, PA), rabbit Aurora-B (ab70238; Abcam), and
mouse anti–α-tubulin, 1:2000 (DM1A; Sigma-Aldrich). Alexa Fluor
594– and 488–conjugated secondary antibodies (Molecular Probes,
Eugene, OR) were used for primary antibody detection at 1:100.
4′,6-Diamidino-2-phenylindole was used for nucleus staining at
0.1 μg/ml (Molecular Probes). Coverslips were mounted using
Prolong Antifade reagent (Molecular Probes) and imaged using
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an Olympus BX-61 microscope with an ORCA-ER CCD camera
(Hamamatsu, Bridgewater, NJ) and UPlanFl 40× or PlanApo 60× objective (Olympus) controlled by SlideBook (Intelligent Imaging
Innovations, Denver, CO). ImageJ (National Institutes of Health,
Bethesda, MD) and GIMP (www.gimp.org/) were used for image
processing. Determination of midbody-stage cells was done by
analysis of α-tubulin staining. Aurora-B inhibition was achieved by
addition of 2 μM ZM447439 (Biomol, Plymouth, PA) 2 h before fixation as indicated.

Live cell imaging
HeLa cells stably expressing GFP-tagged histone H2B (GFP-H2B) or
GFP-tagged tubulin (GFP-tubulin) were seeded on six-well plates,
transfected with either control or LARG targeted siRNA at 10% confluency, and synchronized at G1/S by the double-thymidine method.
After washout, cells were released for 3–4 h before being placed in
a temperature-controlled chamber for filming. Bright-field and GFP
images were acquired every 5 min for 24–36 h using a Nikon TE2000
microscope (Nikon, Tokyo, Japan) controlled by MetaMorph
(Molecular Devices, Sunnyvale, CA). For caspase inhibition experiments, cells were treated with vehicle (DMSO) or 25 μM Z-VAD-FMK
(Santa Cruz Biotechnology) immediately after washout from G1/S
block. ImageJ and GIMP were used for image stack analysis and
montage composition.

RhoA binding assays
LARG plasmids were transfected in HeLa cells as previously described.
After 24 or 48 h of expression, cell lysates were harvested and subjected to GST-G17A-RhoA binding experiments, as described
(Garcia-Mata et al., 2006). Relative levels of binding to transition-state
mimic RhoA were determined by comparison of LARG detected by
immunoblot in pull-down fractions to input as indicated.
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